NasdaqGS:CMPSBiotechs
New Board Appointment At COMPASS Pathways And What It Means For Investors
COMPASS Pathways (NasdaqGS:CMPS) has appointed Kathleen Tregoning to its Board of Directors.
Tregoning brings extensive biotech and pharmaceutical leadership experience, including roles at Cerevel Therapeutics and other large drugmakers.
The appointment is intended to support COMPASS Pathways as it advances late stage programs and prepares for potential commercialization.
For investors tracking mental health treatment companies, COMPASS Pathways focuses on developing therapies for...